SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001114220-17-000016
Filing Date
2017-07-27
Accepted
2017-07-27 07:20:19
Documents
58
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kerx-6302017x10q.htm 10-Q 577734
2 EXHIBIT 3.5 kerx-6302017x10qex35.htm EX-3.5 16456
3 EXHIBIT 3.6 kerx-6302017x10qex36.htm EX-3.6 7662
4 EXHIBIT 31.1 kerx-6302017x10qex311.htm EX-31.1 13503
5 EXHIBIT 31.2 kerx-6302017x10qex312.htm EX-31.2 13097
6 EXHIBIT 32.1 kerx-6302017x10qex321.htm EX-32.1 6053
7 EXHIBIT 32.2 kerx-6302017x10qex322.htm EX-32.2 6101
  Complete submission text file 0001114220-17-000016.txt   3545465

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT kerx-20170630.xml EX-101.INS 643467
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kerx-20170630.xsd EX-101.SCH 30882
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kerx-20170630_cal.xml EX-101.CAL 57104
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kerx-20170630_def.xml EX-101.DEF 131946
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kerx-20170630_lab.xml EX-101.LAB 421801
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kerx-20170630_pre.xml EX-101.PRE 244339
Mailing Address ONE MARINA PARK DR. BOSTON MA 02210
Business Address ONE MARINA PARK DR. BOSTON MA 02210 617-466-3500
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30929 | Film No.: 17984457
SIC: 2834 Pharmaceutical Preparations